Trinity Biotech (TRIB) Treasury Shares (2016 - 2025)

Trinity Biotech has disclosed Treasury Shares across 10 years of filings, most recently posting $24.9 million for Q4 2025.

• Treasury Shares for Q4 2025 came in at $24.9 million, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $24.9 million (changed 0.0% YoY), and the FY2025 annual result was $24.9 million, changed 0.0% from the prior year.
• Treasury Shares came in at $24.9 million for Q4 2025 at Trinity Biotech, up from -$24.9 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $24.9 million in Q4 2024 to a low of -$24.9 million in Q1 2021.
• The 5-year median for Treasury Shares is -$24.9 million (2021), against an average of -$17.3 million.
• Across the five-year window, Treasury Shares changed 0.0% in 2021 and jumped 150.38% in 2023, its largest moves.
• Trinity Biotech's Treasury Shares stood at -$24.9 million in 2021, then changed by 0.0% to -$24.9 million in 2022, then surged by 150.38% to $12.6 million in 2023, then soared by 98.49% to $24.9 million in 2024, then changed by 0.0% to $24.9 million in 2025.
• The last three Treasury Shares figures came in at $24.9 million (Q4 2025), -$24.9 million (Q2 2025), and $24.9 million (Q4 2024), per Business Quant data.